EnroQ

Indications:
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of Pasteurella multocida, Mycoplasma spp. and Actinobacillus pleuropneumoniae. Treatment of infections of the urinary tract caused by enrofloxacin susceptible strains of Escherichia coli. Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome) caused by enrofloxacin susceptible strains of Escherichia coli and Klebsiella spp. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli. Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli.

Dosage & Administration:
Swine: 2.5 mg of enrofloxacin/kg BW, once daily by intramuscular injection for 3 days. Alimentary tract infection, or septicaemia caused by Escherichia coli: 5 mg of enrofloxacin/kg BW, once daily by intramuscular injection for 3 days. In pigs, the injection should be made in the neck at the ear base. Not more than 3 mL should be administered at one intramuscular injection site.

Cautions: 
*Not for human use. 
*Keep out of reach of children.
*People with known hypersensitivity to fluoroquinolones should avoid any contact with the product. Avoid skin and eye contact. Wash any splashes from skin or eyes immediately with water.Wash hands after use. Do not eat, drink or smoke whilst handling the product.
*Care should be taken to avoid accidental self-injection. If accidental self-injection occurs seek medical advice immediately.

Withdrawal Time:

Packing Size:
100 mL/vial；50mL/vial
10%

Storage Conditions:
Store in an airtight container, protected from light.